tirzepatide march 2025 apitegromab Scholar Rock Q2 slides: nears FDA decision with strong cash position By Scholar Rock Reports Positive Phase – Newer Weight-Loss Drugs Not Cost-effective
Pay in 4 interest-free payments of $5.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14

























